CR9751A - Formulaciones topicas con contenido de o-desmetilvenlafaxina (odv) o sus sales. - Google Patents

Formulaciones topicas con contenido de o-desmetilvenlafaxina (odv) o sus sales.

Info

Publication number
CR9751A
CR9751A CR9751A CR9751A CR9751A CR 9751 A CR9751 A CR 9751A CR 9751 A CR9751 A CR 9751A CR 9751 A CR9751 A CR 9751A CR 9751 A CR9751 A CR 9751A
Authority
CR
Costa Rica
Prior art keywords
odv
topical formulations
demetilvenlafaxin
salts
content
Prior art date
Application number
CR9751A
Other languages
English (en)
Inventor
Rao Tatapudy
Syed M Shah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37517243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9751(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR9751A publication Critical patent/CR9751A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion da a conocer composiciones topicas que comprenden O-desmetilvenlafaxina (ODV), un inhibidor selectivo de la serotonina y norepinefrina, o una sal farmaceuticamente aceptable de la misma. En ciertas realizaciones, las formulaciones topicas de la presente invencion contienen uno o mas potenciadores de la absorcion percutanea/permucosal. Tambien se presentan metodos para la preparacion y uso de estas composiciones para el tratamiento de diversas enfermedades y trastornos tales como los sintomas vasomotores y el dolor.
CR9751A 2005-09-07 2008-02-21 Formulaciones topicas con contenido de o-desmetilvenlafaxina (odv) o sus sales. CR9751A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71540005P 2005-09-07 2005-09-07

Publications (1)

Publication Number Publication Date
CR9751A true CR9751A (es) 2008-05-22

Family

ID=37517243

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9751A CR9751A (es) 2005-09-07 2008-02-21 Formulaciones topicas con contenido de o-desmetilvenlafaxina (odv) o sus sales.

Country Status (18)

Country Link
US (1) US20070054964A1 (es)
EP (1) EP1924251A1 (es)
JP (1) JP2009507078A (es)
KR (1) KR20080041695A (es)
CN (1) CN101300002A (es)
AR (1) AR055629A1 (es)
AU (1) AU2006287580A1 (es)
BR (1) BRPI0615769A2 (es)
CA (1) CA2620164A1 (es)
CR (1) CR9751A (es)
EC (1) ECSP088251A (es)
GT (1) GT200600397A (es)
IL (1) IL189598A0 (es)
NO (1) NO20080950L (es)
PE (1) PE20070430A1 (es)
RU (1) RU2008106932A (es)
TW (1) TW200744566A (es)
WO (1) WO2007030537A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2692738A1 (en) * 2007-07-12 2009-01-15 Dr. Reddy's Laboratories, Ltd. O-desmethylvenlafaxine
CA2702664A1 (en) * 2007-10-16 2009-04-23 Alphapharm Pty Ltd Controlled-release pharmaceutical formulation
US8198460B2 (en) * 2007-11-28 2012-06-12 Fresenius Kabi Oncology Ltd. Process for preparation of letrozole and its intermediates
EP2085377A1 (en) * 2008-01-29 2009-08-05 LEK Pharmaceuticals D.D. Novel salts of O-desmethyl-venlafaxine
WO2009155488A2 (en) * 2008-06-19 2009-12-23 Segrub, Llc Novel oxalate salt and crystal of o-desmethylvenlafaxine
WO2010028130A2 (en) * 2008-09-03 2010-03-11 Concert Pharmaceuticals, Inc. Antidepressant compounds
CN103588652B (zh) * 2010-10-01 2015-04-22 山东绿叶制药有限公司 4-甲基苯甲酸4-[2-二甲基胺基-1-(1-羟基环己基)乙基]苯酯盐酸盐的多晶型物、制备方法及其应用
WO2013063794A1 (en) * 2011-11-04 2013-05-10 Oil Crops Research Institute, Chinese Academy Of Agricultural Sciences A growth regulatory factor gene grf2 derived from brassica napus and the use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
PL350924A1 (en) * 1999-04-06 2003-02-10 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
US20020192302A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of antidepressant drugs using basic enhancers
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
DE60221642T3 (de) * 2001-02-12 2017-10-26 Wyeth LLC (n.d.Ges.d. Staates Delaware) O-desmethyl-venlafaxine succinat salz
BR0311693A (pt) * 2002-06-10 2005-03-22 Wyeth Corp Sal de formato de o-desmetil-venlafaxina
US7345096B2 (en) * 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
BRPI0414014A (pt) * 2003-08-26 2006-10-24 Becton Dickinson Co métodos para distribuição intradérmica de agentes terapêuticos
PL1691811T3 (pl) * 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
US20060013866A1 (en) * 2004-07-16 2006-01-19 Carter Stephen G Transdermal drug delivery formulations with optimal amounts of vasodilators therein

Also Published As

Publication number Publication date
TW200744566A (en) 2007-12-16
IL189598A0 (en) 2008-08-07
ECSP088251A (es) 2008-04-28
AU2006287580A1 (en) 2007-03-15
US20070054964A1 (en) 2007-03-08
EP1924251A1 (en) 2008-05-28
JP2009507078A (ja) 2009-02-19
CN101300002A (zh) 2008-11-05
BRPI0615769A2 (pt) 2011-05-24
WO2007030537A1 (en) 2007-03-15
AR055629A1 (es) 2007-08-29
KR20080041695A (ko) 2008-05-13
PE20070430A1 (es) 2007-05-18
NO20080950L (no) 2008-05-26
GT200600397A (es) 2007-08-28
CA2620164A1 (en) 2007-03-15
RU2008106932A (ru) 2009-10-20

Similar Documents

Publication Publication Date Title
CR9751A (es) Formulaciones topicas con contenido de o-desmetilvenlafaxina (odv) o sus sales.
CR8859A (es) Derivados de piridina
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
PA8632801A1 (es) Derivados de tetrahidronaftiridina
CR9954A (es) Derivados de pirazina
CR11789A (es) Formulaciones orales de analogos citidina y metodos para el uso de los mismos
BRPI0515372B8 (pt) composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico
CL2007001918A1 (es) Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras.
GT200600096A (es) Composicion farmaceutica para el tratamiento del cancer
GT200500137A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis.
AR053026A1 (es) Composiciones de anticuerpos anti factor de estimulacion de colonias de macrofagos (anti-m csf)
PA8622001A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
CL2011000144A1 (es) Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros.
CR9246A (es) Formulaciones terapeuticas del factor de crecimiento de queratinocitos
CR9737A (es) Dispositivos de administracion transdermicas de farmacos que contienen o-desmetilvenlafaxina (odv) sus sales.
CR11418A (es) Trans-clomifeno para el sindrome metabolico
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
PA8603001A1 (es) Compuestos utiles para el tratamiento de enfermedades
BR112015023761A2 (pt) moduladores de molécula pequena de pcsk9 e seus métodos e usos
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
UY28979A1 (es) Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3
AR041999A1 (es) Composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida
UY30029A1 (es) Derivados de piperidina, sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones
DOP2009000121A (es) Analogos de pirazol como inhibidores selectivos de 5-lo
CL2008002289A1 (es) Compuestos derivados de n-heteroaril-carboxamidas triciclicas; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar dolor, inflamacion, trastornos metabolicos, trastornos urologicos, entre otros.